429 related articles for article (PubMed ID: 31812844)
1. siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery.
He C; Yue H; Xu L; Liu Y; Song Y; Tang C; Yin C
Acta Biomater; 2020 Feb; 103():213-222. PubMed ID: 31812844
[TBL] [Abstract][Full Text] [Related]
2. Effects of mannose density on in vitro and in vivo cellular uptake and RNAi efficiency of polymeric nanoparticles.
Chu S; Tang C; Yin C
Biomaterials; 2015 Jun; 52():229-39. PubMed ID: 25818429
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages.
He C; Yin L; Tang C; Yin C
Biomaterials; 2013 Apr; 34(11):2843-54. PubMed ID: 23347838
[TBL] [Abstract][Full Text] [Related]
4. Optimization of multifunctional chitosan-siRNA nanoparticles for oral delivery applications, targeting TNF-α silencing in rats.
He C; Yin L; Song Y; Tang C; Yin C
Acta Biomater; 2015 Apr; 17():98-106. PubMed ID: 25662912
[TBL] [Abstract][Full Text] [Related]
5. Trimethyl chitosan-cysteine nanoparticles for systemic delivery of TNF-α siRNA via oral and intraperitoneal routes.
He C; Yin L; Tang C; Yin C
Pharm Res; 2013 Oct; 30(10):2596-606. PubMed ID: 23715740
[TBL] [Abstract][Full Text] [Related]
6. Galactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophages.
Zhang J; Tang C; Yin C
Biomaterials; 2013 May; 34(14):3667-77. PubMed ID: 23419643
[TBL] [Abstract][Full Text] [Related]
7. Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-ɑ siRNA provide a novel strategy for the experimental treatment of ulcerative colitis.
Huang Y; Guo J; Gui S
Eur J Pharm Sci; 2018 Dec; 125():232-243. PubMed ID: 30315858
[TBL] [Abstract][Full Text] [Related]
8. Effects of particle size and binding affinity for small interfering RNA on the cellular processing, intestinal permeation and anti-inflammatory efficacy of polymeric nanoparticles.
Cheng W; Tang C; Yin C
J Gene Med; 2015; 17(10-12):244-56. PubMed ID: 26418829
[TBL] [Abstract][Full Text] [Related]
9. Caveolae-Mediated Endocytosis Drives Robust siRNA Delivery of Polymeric Nanoparticles to Macrophages.
Song Y; Wu Y; Xu L; Jiang T; Tang C; Yin C
ACS Nano; 2021 May; 15(5):8267-8282. PubMed ID: 33915044
[TBL] [Abstract][Full Text] [Related]
10. TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis.
Xiao B; Chen Q; Zhang Z; Wang L; Kang Y; Denning T; Merlin D
J Control Release; 2018 Oct; 287():235-246. PubMed ID: 30107214
[TBL] [Abstract][Full Text] [Related]
11. Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy.
Xiao B; Laroui H; Ayyadurai S; Viennois E; Charania MA; Zhang Y; Merlin D
Biomaterials; 2013 Oct; 34(30):7471-82. PubMed ID: 23820013
[TBL] [Abstract][Full Text] [Related]
12. Effects of tripolyphosphate on cellular uptake and RNA interference efficiency of chitosan-based nanoparticles in Raw 264.7 macrophages.
Xiao B; Ma P; Ma L; Chen Q; Si X; Walter L; Merlin D
J Colloid Interface Sci; 2017 Mar; 490():520-528. PubMed ID: 27918990
[TBL] [Abstract][Full Text] [Related]
13. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells.
Song Y; Tang C; Yin C
Biomaterials; 2018 Dec; 185():117-132. PubMed ID: 30241030
[TBL] [Abstract][Full Text] [Related]
14. Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.
Han L; Tang C; Yin C
Biomaterials; 2014 May; 35(15):4589-600. PubMed ID: 24613049
[TBL] [Abstract][Full Text] [Related]
15. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.
Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X
Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978
[TBL] [Abstract][Full Text] [Related]
16. Urocanic acid-modified chitosan nanoparticles can confer anti-inflammatory effect by delivering CD98 siRNA to macrophages.
Xiao B; Ma P; Viennois E; Merlin D
Colloids Surf B Biointerfaces; 2016 Jul; 143():186-193. PubMed ID: 27011348
[TBL] [Abstract][Full Text] [Related]
17. Ternary polymeric nanoparticles for oral siRNA delivery.
Zhang J; He C; Tang C; Yin C
Pharm Res; 2013 May; 30(5):1228-39. PubMed ID: 23307349
[TBL] [Abstract][Full Text] [Related]
18. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D
Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741
[TBL] [Abstract][Full Text] [Related]
19. RNAi using a chitosan/siRNA nanoparticle system: in vitro and in vivo applications.
Andersen MØ; Howard KA; Kjems J
Methods Mol Biol; 2009; 555():77-86. PubMed ID: 19495689
[TBL] [Abstract][Full Text] [Related]
20. TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis.
Lee SJ; Lee A; Hwang SR; Park JS; Jang J; Huh MS; Jo DG; Yoon SY; Byun Y; Kim SH; Kwon IC; Youn I; Kim K
Mol Ther; 2014 Feb; 22(2):397-408. PubMed ID: 24145554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
